Stock PTIX PROTAGENIC THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Protagenic Therapeutics, Inc.

Equities

PTIX

US74365N2027

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-06-28 EDT 		5-day change 1st Jan Change
0.905 USD +0.56% Intraday chart for Protagenic Therapeutics, Inc. -9.50% -8.59%
05-15 Protagenic Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-01 Protagenic Therapeutics, Inc. Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director
CI
Protagenic Therapeutics, Inc. Announces Audit Committee Changes
CI
Protagenic Therapeutics, Inc. Appoints Jennifer Buell as a Member of the Board
CI
Protagenic Therapeutics, Inc. Announces Board Changes
CI
Protagenic Therapeutics, Inc. Announces Resignation of Gregory K. Ekizian as Director and Chairman of the Audit Committee
CI
Atrinsic, Inc. Creases Robert Ziroyan as Interim President and Chief Operating Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTIX Stock
  4. News Protagenic Therapeutics, Inc.
  5. Insiders